REDWOOD SHORES, CA, Jan 31 (Marketwire) --
Oracle (NASDAQ: ORCL)
-- MD Anderson, one of the world's most respected centers devoted
exclusively to cancer patient care, research, education and
prevention, has selected Oracle Health Sciences applications and
Oracle technology as the foundation for an organization-wide analytics
initiative designed to enable a new generation of personalized cancer
treatment that improves outcomes. The platform will also support the
center's renowned Moon Shots Program, an unprecedented effort to
dramatically accelerate the pace of converting scientific discoveries
into clinical advances that reduce cancer deaths.
-- Oracle applications and technology will power the enterprise analytics
initiative, one of the program's platforms. The new platform will
bring together clinical, genomic, financial, administrative and
operational information from internal and external sources to yield
insights that drive care innovation and optimize operational
-- To achieve its goals, the center, ranked first for cancer care in U.S.
News & World Report's "Best Hospitals" survey for seven of the
last nine years, will deploy a wide range of Oracle solutions,
including Oracle Enterprise Healthcare Analytics.
-- MD Anderson, which sees data growth of 30 percent to 40 percent
annually, is also deploying Oracle Database and Oracle Business
Intelligence Enterprise Edition.
-- "MD Anderson, in its quest to continuously improve cancer care
outcomes and quality of life for patients, has built a culture of
innovation that consistently delivers life-changing gains for cancer
patients. As we focus on the next-generation of treatments --
including our Moon Shots Program -- we require a powerful analytical
infrastructure that can yield new insight from the unprecedented
volume of data available today. Oracle's integrated health sciences
applications, enterprise applications and technology stack will help
provide one of the robust foundations that we need to accelerate
deployment, and ultimately, discovery of life-saving treatments," said
Dr. John Frenzel, chief medical information officer, MD Anderson.
-- "Leveraging data and information to drive more effective resource
utilization, improve operational efficiency, and level patient volumes
across the days of the week is becoming increasingly more important.
Through the use of Oracle Enterprise Healthcare Analytics, we are
creating the platform to improve delivery of actionable information to
our customers so they can effectively improve processes," said Craig
Owen, director of clinical analytics and informatics, MD Anderson.
-- "MD Anderson is recognized globally for its ground-breaking research
and life-saving advances in cancer care. Its next generation analytics
initiative, built on industry-leading platforms like Oracle Enterprise
Healthcare Analytics and Oracle technology, stands to further amplify
healthcare insight and accelerate innovation," said Neil de Crescenzo,
senior vice president and general manager, Oracle Health Sciences. "We
are honored to be a part of this important initiative and to be
working with such a world leader in oncology research and care."
-- Oracle in Health Sciences
-- MD Anderson Launches Unprecedented Moon Shots Program
-- MD Anderson Chooses Oracle as Strategic Partner
-- Oracle Enterprise Healthcare Analytics
-- Follow Oracle Health Sciences on Twitter
-- Join the Oracle Health Sciences Community on Facebook
-- Oracle Health Sciences on YouTube
Oracle engineers hardware and software to work
together in the cloud and in your data center. For more information about
Oracle (NASDAQ: ORCL), visit www.oracle.com.
About Oracle in Industries
Oracle industry solutions leverage the
company's best-in-class portfolio of products to address complex business
processes relevant to health sciences, helping speed time to market,
reduce costs, and gain a competitive edge.
Oracle and Java
are registered trademarks of Oracle and/or its affiliates. Other names
may be trademarks of their respective owners.
O'Keeffe & Company
Copyright 2013, Marketwire, All rights reserved.